Fady Ibraham Malik Cytokinetics Inc (CYTK) insider trading activity

Fady Ibraham Malik is EVP Research & Development of CYTOKINETICS INC. Currently has a direct ownership of 140,255 shares of CYTK, which is worth approximately $5.58 Million. The most recent transaction as insider was on Mar 02, 2022, when has been sold 5,004 shares (Common Stock) at a price of $37.63 per share, resulting in proceeds of $188,301. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K

20.84% 3M change

1.33% 12M change

Total Value Held $5.58 Million

Fady Ibraham Malik Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 02 2022	SELL Payment of exercise price or tax liability	$188,301 $37.63 p/Share	5,004 Reduced 3.27%	148,000 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	30,000 Added 14.42%	178,000 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$122,137 $35.32 p/Share	3,458 Reduced 2.21%	153,004 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	7,148 Added 4.37%	156,462 Common Stock
Dec 09 2021	SELL Open market or private sale	$1,064,267 $36.49 p/Share	29,166 Reduced 16.34%	149,314 Common Stock
Dec 09 2021	BUY Exercise of conversion of derivative security	$183,746 $6.3 p/Share	29,166 Added 14.49%	172,053 Common Stock
Nov 11 2021	SELL Open market or private sale	$79,120 $39.56 p/Share	2,000 Reduced 1.33%	148,878 Common Stock
Oct 14 2021	SELL Open market or private sale	$75,460 $37.73 p/Share	2,000 Reduced 1.31%	150,878 Common Stock
Sep 09 2021	SELL Open market or private sale	$62,860 $31.43 p/Share	2,000 Reduced 1.29%	152,878 Common Stock
Aug 12 2021	SELL Open market or private sale	$65,200 $32.6 p/Share	2,000 Reduced 1.27%	154,878 Common Stock
Jul 08 2021	SELL Open market or private sale	$38,960 $19.48 p/Share	2,000 Reduced 1.26%	156,878 Common Stock
Jun 10 2021	SELL Open market or private sale	$42,960 $21.48 p/Share	2,000 Reduced 1.24%	158,878 Common Stock
May 13 2021	SELL Open market or private sale	$48,840 $24.42 p/Share	2,000 Reduced 1.23%	160,348 Common Stock
Apr 08 2021	SELL Open market or private sale	$46,780 $23.39 p/Share	2,000 Reduced 1.22%	162,348 Common Stock
Mar 11 2021	SELL Open market or private sale	$39,800 $19.9 p/Share	2,000 Reduced 1.2%	164,348 Common Stock
Mar 08 2021	SELL Payment of exercise price or tax liability	$146,496 $19.19 p/Share	7,634 Reduced 4.39%	166,348 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	35,000 Added 16.75%	173,982 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$54,399 $19.66 p/Share	2,767 Reduced 1.95%	138,982 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$132,234 $18.73 p/Share	7,060 Reduced 4.74%	141,749 Common Stock
Feb 11 2021	SELL Open market or private sale	$38,091 $23.34 p/Share	1,632 Reduced 1.08%	148,809 Common Stock
Jan 14 2021	SELL Open market or private sale	$240,625 $19.25 p/Share	12,500 Reduced 7.67%	150,441 Common Stock
Jan 14 2021	BUY Exercise of conversion of derivative security	$117,750 $9.42 p/Share	12,500 Added 7.15%	162,324 Common Stock
Dec 10 2020	SELL Open market or private sale	$21,177 $20.13 p/Share	1,052 Reduced 0.69%	150,441 Common Stock
Nov 12 2020	SELL Open market or private sale	$21,112 $17.15 p/Share	1,231 Reduced 0.81%	150,951 Common Stock
Oct 08 2020	SELL Open market or private sale	$21,952 $17.45 p/Share	1,258 Reduced 0.82%	152,182 Common Stock

Also insider at

RCKT

ROCKET PHARMACEUTICALS, INC. Healthcare

FIM

Fady Ibraham Malik

EVP Research & Development

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account